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Abstract
Background: Brucellosis continues to be an important source of morbidity in several countries,
particularly among agricultural and pastoral populations. The purpose of this study was to examine
if there is an effect on the incidence of human brucellosis after the implementation of an animal
brucellosis control programme.
Methods: The study was conducted in the Municipality of Tritaia in the Prefecture of Achaia in
Western Greece during the periods 1997–1998 and 2000–2002. Health education efforts were
made during 1997–1998 to make the public take preventive measures. In the time period from
January 1999 to August 2002 a vaccination programme against animal brucellosis was realised in
the specific region. The vaccine used was the B. melitensis Rev-1 administered by the conjuctival
route. Comparisons were performed between the incidence rates of the two studied periods.
Results:  There was a great fall in the incidence rate between 1997–1998 (10.3 per 1,000
population) and the period 2000–2002 after the vaccination (0.3 per 1,000 population). The
considerable decrease of the human incidence rate is also observed in the period 2000–2002
among persons whose herds were not as yet vaccinated (1.4 vs. 10.3 per 1,000 population),
indicating a possible role of health education in the decline of human brucellosis.
Conclusion:  The study reveals a statistically significant decline in the incidence of human
brucellosis after the vaccination programme and underlines the importance of an ongoing control
of animal brucellosis in the prevention of human brucellosis. The reduction of human brucellosis
can be best achieved by a combination of health education and mass animal vaccination.
Background
Brucellosis, a zoonotic illness caused by different species
of Brucella, remains a serious problem of public health for
countries around the Mediterranean Sea, Arabic Peninsula
and some countries in Latin America and Asia [1]. These
pathogenic bacteria can not only infect sheep, goats, cat-
tle, pigs and camels, but humans as well. B. melitensis
(sheep and goats) is the most important causative agent
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for human brucellosis followed by B. abortus (cattle), B.
suis (pigs) and B. canis (dogs).
Brucellosis is endemic in Greece; however incidence,
where reported, is likely to underestimate the true disease
burden. B. melitensis is the most common pathogen in
Greece [2]. In the period from 1993 to 2000 there had
been an increase in the reported cases from 112 to 548
cases (1.1 to 5.0 per 100,000), whereas after the year 2000
a remarkable decrease in the number of reported cases was
observed (2.2 per 100,000 in 2003) [3]. However, recent
studies reported an annual incidence of 17.3 – 1,110 per
100,000 population for human brucellosis in certain rural
areas of Greece [4-6].
Control strategies available to prevent human brucellosis
are pasteurization of milk, livestock vaccination and elim-
ination of infected animals. In animal populations, con-
trol of infection can be based on different strategies the
selection of which depends on numerous factors. Mass
vaccination accompanied by a strict surveillance scheme is
a first step to reduce the number of infected animals and
hence the infection pressure in regions where the inci-
dence rate of animal brucellosis is high [7]. At a low level
of infection a test-and-slaughter programme can be
applied in order to attain brucellosis free flocks and zones
[8]. The most commonly used vaccines are B. melitensis
Rev-1 and B. abortus S19 vaccines. B. abortus RB51 vaccine
is used in some countries on a small scale [9]. The B.
melitensis Rev-1 strain is currently considered as the best
vaccine available for the control of ovine and caprine bru-
cellosis, especially when used at the standard dose by the
conjunctival route [10].
The Greek Ministry of Agriculture, in a co-operation with
the European Union, applied a countrywide vaccination
programme in order to reduce the incidence of animal
brucellosis [11]. Since the incidence of human brucellosis
correlates with the extent of an animal vaccination pro-
gramme, it is very interesting to investigate the degree of
the decline in the incidence of human brucellosis in those
areas where vaccination was applied. Therefore, the main
objective of this study was to investigate the above effect
of animal vaccination on human brucellosis incidence
rate and additionally to investigate the impact of health
education on the disease incidence.
Methods
The study was conducted in the Municipality of Tritaia in
the Prefecture of Achaia in Western Greece during the
periods 1997–1998 (first period) and again during 2000–
2002 (second period). The mean population of the stud-
ied area in this period was 6,121 according to the census
of the year 2001. The population of the region is mainly
pastoral (stock-breeders whose main source of income
comes from selling dairy products, meat, eggs etc.) and
the incidence of both animal and human brucellosis was
very high until the year 1998 in relation to the national
incidence of the disease (1.1 per 100,000 – 4.2 per
100,000 from 1993–1998 for human brucellosis).
During the first period (1997–1998) a case-control study
was conducted, in order to investigate risk factors as well
as a simultaneous incidence rate study [4]. This study
comprised 123 patients who were examined in the local
Health Centre for diagnosis or follow-up as well as 274
controls from the same region matched for age and gen-
der. Diagnosis of the human brucellosis was established
by the positive Standard Agglutination Test (SAT) where a
titer of ≥1/160 or increasing in time in addition to defined
clinical symptoms and signs such as fever, fatigue, arthral-
gia etc. was considered positive. In all cases, we considered
a diagnosis to be a long term process of more than two
weeks, during which clinical examination is performed
several times as well as the Standard Agglutination Test.
No brucella cultivation was performed but successful spe-
cific treatment was also used as a diagnostic criterion of
the disease. Given that the follow up (including the pre-
scription of drugs) of all cases was performed exclusively
by the local medical staff, it can be concluded that this
study comprised almost all patients in the region during
the studied periods.
All participants in this study received home visits, during
which health education talks were organised to all family
members of the participants. During these talks contami-
nation conditions were described and analyzed in detail.
For instance, emphasis was made on milk pasteurization,
use of individual protection devices during delivery, milk-
ing and slaughtering (gloves, mask). All the above ele-
ments were revealed to be important contamination
factors as shown in the previous case-control study [4]. It
should be added that public health education efforts
(radio broadcasts, open public meetings, etc.) were per-
formed by the local Health Centre's medical staff. The eco-
nomic benefits of disease control for both animal and
human brucellosis was particularly stressed to the whole
population of the studied area.
In the time period between September 1999 and August
2002 an animal vaccination campaign was conducted by
the Field Veterinary Service (FVS) of the Greek Ministry of
Agriculture in addition to other eradication efforts such as
health education of the population and animal move-
ment control which included an official veterinary certifi-
cate by the FVS (Table 1). This certificate contained
detailed information on the health status of the flock, the
purpose of the movement and the final destination, espe-
cially during transhumance period. The final objectiveBMC Public Health 2008, 8:241 http://www.biomedcentral.com/1471-2458/8/241
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was to establish that flocks grazing in common pastures
must have the same health status.
The vaccination programme included the vaccination of
all non-pregnant female sheep and goats aged over three
months. The detailed descriptions of vaccination methods
are found in the annual reports of the Food and Veterinary
Office (FVO) of the European Commission [12]. The vac-
cine used was the B. melitensis Rev-1 (since B. melitensis is
the main and most frequent pathogenic species in Greece)
and was administered by the conjunctival route. Exclu-
sively veterinary medical officers performed all vaccina-
tions while health assistants immobilized the animal.
Each dosage contained 1 × 109 CFU. The vaccination pro-
gramme included almost all herds of the investigated
region. Being more specific, at the end of the campaign,
676 out of 683(99%) herds were vaccinated, accounting
for 88,005 of the 88,639 (99.3%) sheep and goats. The
small number of dropouts was due to herds temporarily
moving outside the study area and consequently, escaping
the vaccination.
In the second period (2000–2002) of the study only an
incidence rate study was realized in order to investigate
the incidence of human brucellosis in persons whose
herds were vaccinated and in persons whose herds were
not yet vaccinated.
Comparisons were performed between the incidence rates
of the two studied periods, i.e. before the vaccination
campaign (1997–1998) and during the vaccination pro-
gramme (2000–2002), separating those whose herds were
vaccinated and those whose herds were not yet vacci-
nated.
Statistical analysis was performed by SPSS v. 15 statistical
package (SPSS Inc. USA). Kolmogorov-Smirnov-test was
applied in order to compare age distribution of cases
before and after the vaccination campaign so that age
deviations could be linked to variations in contamination
conditions. Poisson regression was employed to assess the
incidence rate ratios between the different time periods.
The structure of the model was 
where mi, j denotes the incidence rate ratio for ith age group
(i = 1,2...8), and jth time period (j = 1,2), Ni, j the corre-
sponding estimated population at risk, αi represents the
effect for ith age group and βj represents the jth time period
effect.
The Plenary meeting of the School of Medicine approved
the investigation, which was conducted by the staff of the
Department of Public Health of University of Patras and
the staff of the Health Centre of Erymanthia. Verbal con-
sent was obtained from all study subjects.
Results
Table 2 presents the annual incidence rates of human bru-
cellosis per 1,000 population in the time period of 1997–
1998 (before implementation of the vaccination pro-
gramme) and 2000–2002 when vaccination programme
was running, separating persons whose herds were already
vaccinated and persons whose herds were not yet vacci-
nated.
During the second period (2000–2002) a statistically sig-
nificant reduction of the incidence rate was observed,
mN e ij ij
ij
,, * =
++ μα β
Table 1: Annual animal vaccination coverage in Tritaia in the 
years 1999–2002
Herds Animals
Year N % Cum % N % Cum %
1999 24 3.5 3.5 15269 17.2 17.2
2000 156 22.8 26.3 22097 24.9 42.1
2001 476 69.7 96.0 48192 54.4 96.5
2002 20 2.9 98.9 2447 2.8 99.3
Unvaccinated 7 1.0 100 634 0.7 100
Total 683 100 88639 100
Table 2: Annual incidence rates of human brucellosis per 1000 population in the study area
Period 1997–1998* 1997 1998 Mean incidence
13.2 (79)** 7.3 (44) 10.3 (123)
Period 2000–2002*** 2000 2001 2002 Mean incidence
before vaccination 1.1 (7) 2.5 (15) 0.5 (3) 1.4 (25)
after vaccination 0.0 (0) 0.2 (1) 0.7 (4) 0.3 (5)
total 1.1 (7) 2.7 (16) 1.2 (7) 1.7 (30)
* mean population: 5996
** in brackets, number of cases
*** mean population: 6121BMC Public Health 2008, 8:241 http://www.biomedcentral.com/1471-2458/8/241
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mainly between the period 1997–1998 (i.e. before vacci-
nation – 10.3 per 1,000 population) and the period
2000–2002 after vaccination (0.3 per 1,000 population, p
< 0.001). The reduction in the incidence has been already
seen in 1998 (7.3 vs 13.2 per 1000), one year after health
education was started. Statistically significant decrease in
the human incidence rate is also observed in the period
2000–2002 even in persons, whose herds were not as yet
vaccinated (1.4 vs. 10.3 per 1,000 population, p < 0.001).
A further statistical significant reduction (0.3 vs 1.4 per
1000 population, 5 times lower) was achieved in persons
whose herds were vaccinated, a fact that demonstrates the
considerable effectiveness of the animal vaccination in the
decline of human brucellosis [13] (see Tables 2 and 3).
It is notable, as indicated in Table 4, that the age distribu-
tion of cases in 1997–1998 and 2000–2002 is quite iden-
tical and therefore the influences, which decrease the
incidence of the disease, appear to be spread homoge-
nously in the population.
Discussion
In many countries it has been observed that there is a very
close positive correlation between incidence of brucellosis
in animals and incidence of the disease in humans [14].
Therefore, animal vaccination should considerably influ-
ence the human incidence of the disease. Furthermore,
studies of risk factors have concluded that several behav-
ioural items (dairy products consumption, animal deliv-
ery practices) play a very important role in the spread of
the disease [4]. The respective role of vaccination and
health education is a very important subject of future
studies. In this study we have observed that there is a sub-
stantial reduction in the annual incidence rate between
the two studied periods in persons whose herds were not
yet vaccinated. This reduction could be attributed partially
to the health education efforts and the changes in hazard-
ous habits (pasteurization of dairy products, using masks
and gloves, especially during animal delivery etc.). More-
over, a favourable role plays the fact that in the period
2000–2002, a lot of herds were already and gradually vac-
cinated and therefore contamination conditions were
somehow modified even in persons whose herds were not
as yet vaccinated.
The fact that the incidence rate after the animal vaccina-
tion was decreased from 1.1 to 0.3 per 1,000 population
indicates that reduction of human brucellosis may be real-
ized, proved that animal vaccination is correctly and com-
pletely performed and health education is well
established in the population. The small number of cases
(five in the studied area) identified after vaccination cam-
paign was probably due to the exposure to infected mate-
rial, food or animals in that area or from other regions. In
fact, although it is known that vaccine itself can be an
infective agent to man, we have not identified any possi-
ble contamination of the cases by the vaccine itself given
that none of them was involved in vaccination process
[15].
These results are in agreement with the results of Minas A.
et al. who has observed that there is a very close correla-
tion between vaccination programmes and human inci-
dence rate; and in cases where vaccination was very
intensive, human incidence rate was declining signifi-
cantly [16]. In contrast, whenever animal vaccination was
interrupted, human incidence rate tended to increase con-
siderably, especially in cases where no health education
programmes were ever implemented [14,16].
Our results demonstrate that even when time period is not
taken into consideration (as in period 2000–2002, when
incidence rate declined from 1.4 to 0.3 per 1,000 popula-
tion) the vaccination of one's herd appears to decrease
considerably the probability of contamination of the fam-
ily members.
Brucellosis has serious economic effects in the local pop-
ulation and can cause serious problems in the national
agricultural economy as well. Since slaughtering is the
only solution when an animal is infected it is obvious that
a high incidence of animal brucellosis leads to great losses
in breeder's income. In Mongolia, a well-designed survey
was conducted recently in order to estimate the economic
benefits from livestock vaccination for brucellosis, where
the total costs for the vaccination (vaccines, veterinaries
fees, transportations, ear tagging etc) were compared to
the economic benefits after vaccination, such as avoidance
of losses in animals and animal products, decline in the
human disability to work, reduction of treatments cost etc
Table 3: Incidence rate ratios of human brucellosis between periods 1997–1998 and 2000–2002
Period Incidence rate ratio* 95% C.I.
2000–2002 vs 1997–1998 0.15 0.10 – 0.23
2000–2002 (bv**) vs 1997–1998 0.13 0.09 – 0.20
2000–2002 (av***) vs 2000–2002 (bv**) 0.20 0.08 – 0.52
* Poisson regression
** before vaccination
*** after vaccinationBMC Public Health 2008, 8:241 http://www.biomedcentral.com/1471-2458/8/241
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[17]. The study demonstrated a high cost-effectiveness of
the vaccination and a theoretical great net economic ben-
efit for the farmers. Unfortunately, in Greece, no cost-
effectiveness studies have been performed till now to sup-
port similar financial benefits from livestock vaccination.
Conclusion
In this study we observed that a considerable reduction of
incidence of the disease was achieved by combination of
health education and animal vaccination. The incidence
rate decreased from 13.2 per 1,000 population in 1997 to
0.7 per 1,000 population in 2002 after animal vaccina-
tion. It is obvious that the reduction of brucellosis in both
animals and humans can be achieved with a mass animal
vaccination in combination with health education,
improving not only farmer's health but their economic
situation as well.
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Table 4: Age contribution of cases in the periods 1997–98 and 2000–02 (both sexes)
1997–1998 2000–2002
Age groups Cumulative frequency Cumulative percent (%) Cumulative frequency Cumulative percent (%)
0 – 9 6513
0–19 17 14 3 10
0–29 35 28 7 23
0–39 49 40 9 30
0–49 67 54 17 57
0–59 84 68 21 70
0–69 105 85 25 83
0–80 123 100 30 100
p >0.05 (Kolmogorov-Smirnov test)
* Poisson regression ** before vaccination *** after vaccination